Literature DB >> 12446368

Protective role of oral antioxidant supplementation in ocular surface of diabetic patients.

V Peponis1, M Papathanasiou, A Kapranou, C Magkou, A Tyligada, A Melidonis, T Drosos, N M Sitaras.   

Abstract

AIM: To investigate the effect of vitamin C and E supplementation in the levels of nitrite, nitric oxide (NO) related metabolite, and ocular surface parameters in diabetic patients.
METHODS: 50 patients with non-insulin dependent diabetes mellitus were given vitamin C (1000 mg/day) and vitamin E (400 IU/day) supplementation for 10 days. Nitrite levels in tears were measured by photometric determination before and after vitamin supplementation. Tear function parameters (Schirmer test I, BUT, ocular ferning test) and brush cytology analysis of the conjunctival epithelium were also evaluated.
RESULTS: Nitrite levels were found to be significantly reduced (p<0.05) after 10 days of vitamin C and E supplementation. Improved values for Schirmer test, BUT test, and ocular ferning test were also found. Goblet cell density and grading of squamous metaplasia showed a significant improvement.
CONCLUSIONS: Oxidative stress and free radical production are elevated in diabetes mellitus. Antioxidants, such as vitamin C and vitamin E, probably have an important role in reducing the oxidative damage produced by nitric oxide and other free radicals and improving the ocular surface milieu.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446368      PMCID: PMC1771432          DOI: 10.1136/bjo.86.12.1369

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  53 in total

1.  Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus.

Authors:  M Dogru; C Katakami; M Inoue
Journal:  Ophthalmology       Date:  2001-03       Impact factor: 12.079

Review 2.  New approaches for treatment in diabetes: aldose reductase inhibitors.

Authors:  N Hotta
Journal:  Biomed Pharmacother       Date:  1995       Impact factor: 6.529

Review 3.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Possible mechanisms for the loss of goblet cells in mucin-deficient disorders.

Authors:  S C Tseng; L W Hirst; A E Maumenee; K R Kenyon; T T Sun; W R Green
Journal:  Ophthalmology       Date:  1984-06       Impact factor: 12.079

5.  Diabetic keratopathy.

Authors:  R O Schultz; D L Van Horn; M A Peters; K M Klewin; W H Schutten
Journal:  Trans Am Ophthalmol Soc       Date:  1981

Review 6.  Does diabetes mellitus increase the requirement for vitamin C?

Authors:  J C Will; T Byers
Journal:  Nutr Rev       Date:  1996-07       Impact factor: 7.110

Review 7.  Nitric oxide in the eye: multifaceted roles and diverse outcomes.

Authors:  F Becquet; Y Courtois; O Goureau
Journal:  Surv Ophthalmol       Date:  1997 Jul-Aug       Impact factor: 6.048

Review 8.  Advanced protein glycosylation in diabetes and aging.

Authors:  M Brownlee
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

9.  Impression cytology in patients with keratoconjunctivitis sicca.

Authors:  M V de Rojas; M T Rodriguez; J A Ces Blanco; M S Salorio
Journal:  Cytopathology       Date:  1993       Impact factor: 2.073

Review 10.  Diabetic microvascular complications and growth factors.

Authors:  A Pfeiffer; H Schatz
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

View more
  14 in total

Review 1.  New insights into the mechanisms of diabetic neuropathy.

Authors:  Andrea M Vincent; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  [Vitamins for the eyes? Risks and opportunities for physician and patient].

Authors:  R Grossklaus; K J Henning
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

3.  Oxidative stress-dependent MMP-13 activity underlies glucose neurotoxicity.

Authors:  Ashley L Waldron; Patricia A Schroder; Kelly L Bourgon; Jessie K Bolduc; James L Miller; Adriana D Pellegrini; Amanda L Dubois; Magdalena Blaszkiewicz; Kristy L Townsend; Sandra Rieger
Journal:  J Diabetes Complications       Date:  2017-12-06       Impact factor: 2.852

Review 4.  Optical quality of the diabetic eye: a review.

Authors:  A M Calvo-Maroto; R J Perez-Cambrodí; C Albarán-Diego; A Pons; A Cerviño
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

5.  Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats.

Authors:  M Alves; V C Calegari; D A Cunha; M J A Saad; L A Velloso; E M Rocha
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

6.  Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy.

Authors:  Junghyun Kim; Chan-Sik Kim; Eunjin Sohn; Il-Ha Jeong; Hyojun Kim; Jin Sook Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

7.  IFN-γ-independent intraocular tumor rejection is mediated by a macrophage-dependent process that leaves the eye intact.

Authors:  Terry G Coursey; Peter W Chen; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2012-06-12       Impact factor: 4.962

8.  Changes of tear film and tear secretion after phacoemulsification in diabetic patients.

Authors:  Xi Liu; Yang-shun Gu; Ye-sheng Xu
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

9.  Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.

Authors:  David Cheishvili; Channa Maayan; Naama Holzer; Jeanna Tsenter; Elad Lax; Sophie Petropoulos; Aharon Razin
Journal:  J Mol Neurosci       Date:  2016-04-30       Impact factor: 3.444

10.  Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats.

Authors:  Carolina Maria Módulo; Angélica Gobbi Jorge; Ana Carolina Dias; Alexandre Martins Braz; Rubens Bertazolli-Filho; Alceu A Jordão; J Sérgio Marchini; Eduardo M Rocha
Journal:  Endocrine       Date:  2009-06-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.